Plus Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 1.23%540.331.0%$620.38m
DHRDanaher Corp. -0.10%297.320.7%$603.80m
ABTAbbott Laboratories -0.12%120.940.8%$567.87m
ISRGIntuitive Surgical, Inc. 1.02%991.462.3%$461.57m
MDTMedtronic Plc 0.46%131.280.6%$455.56m
ALGNAlign Technology, Inc. 2.78%695.806.3%$417.38m
NURONeuroMetrix, Inc. -7.11%14.907.7%$334.47m
DXCMDexCom, Inc. 13.04%515.517.8%$331.96m
SYKStryker Corp. 0.69%271.041.3%$324.45m
BSXBoston Scientific Corp. 0.71%45.641.0%$283.99m
AAgilent Technologies, Inc. 0.32%153.161.6%$279.08m
EWEdwards Lifesciences Corp. 0.56%112.240.4%$277.69m
BDXBecton, Dickinson & Co. 0.14%255.671.0%$258.67m
IDXXIDEXX Laboratories, Inc. -3.64%678.533.8%$248.19m
BAXBaxter International, Inc. 0.08%77.441.8%$219.11m

Company Profile

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. It focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.